Milliporesigma Brochures

  1. A High-Purity Excipient Suitable For High-Risk Vaccine Applications 7/21/2025

    Examine an ultra-pure, sustainable alternative to shark-derived squalene. With ā‰„99% purity, it ensures safety, consistency, and ethical sourcing for innovation.

  2. An Alternative Suitable For High-Risk Applications 7/21/2025

    Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.

  3. AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone 6/17/2025

    Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.

  4. Conical Tube Sampling Unit 6/16/2025

    Enhance your biopharmaceutical sampling process with compact, centrifuge-ready containers that are designed for flexibility, aseptic transfer, and contamination control at any production stage.

  5. MGB:EDQ Probes For qPCR 9/19/2024

    An MGB:EDQ probe is a single-stranded oligonucleotide labeled with two differing dyes. Explore the applications and advantages of MGB:EDQ probes for qPCR.

  6. RobocolumnĀ® And MiniChrom Chromatography Columns 7/19/2024

    Learn in detail about small-scale prepacked chromatography columns for accelerated process development, method optimization, parameter screening, and sample preparation.

  7. Viral Clearance Studies To Meet Your Timelines 7/8/2024

    Explore comprehensive services tailored to meet your needs from a company with proven expertise in viral clearance. Choose from four global locations and three service packages.

  8. Viral Vector CTDMO Services 6/19/2024

    Discover a trusted partner with the expertise to optimize the production of your cell or gene therapy whether you use traditional, non-traditional, or novel vectors.

  9. Accelerating Adenovirus-Based Cell And Gene Therapy Manufacturing 6/12/2024

    Learn about a trusted partner that can expedite your adenovirus development and manufacturing, whether you are seeking to transfer an existing process or require a new, optimized process.

  10. A Platform For Lentivirus-Based Cell And Gene Therapy Manufacturing 5/13/2024

    Discover solutions to de-risk the production of your cell or gene therapy and bring your lentivirus-based therapy to GMP in less than 12 months.